Effects of the COX-2 Inhibitor FK3311 on Ischemia—Reperfusion Injury in the Rat Lung

REFERENCES

• McFadden P M, Emory W B. Lung transplantation. Surg Clin North Am. 1998; 78: 749–762
   PubMed Web of Science ®Google Scholar
• Kirk A J, Colquhoun I W, Dark J H. Lung preservation: A review of current practice and future directions. Ann Thorac Surg. 1993; 56: 990–1000
   PubMed Web of Science ®Google Scholar
• Keck B M, Bennett L E, Fiol B S, Daily O P, Novick R J, Hosenpud J D. Worldwide thoracic organ transplantation: A report from the UNOS/ISHLT International Registry for thoracic organ transplantation. Clin Transpl. 1996; 10: 31–45
   Google Scholar
• Hosenpud J D, Novick R J, Bennett L E, Keck B M, Fiol B, Daily O P. The Registry of the International Society for Heart and Lung Transplantation: Thirteenth Official Report—1996. J Heart Lung Transplant 1996; 15: 655–674
   PubMed Web of Science ®Google Scholar
• Urabe N, Fujisawa T, Saitoh Y, et al. The capacity of dog lung to release prostaglandin I2 as a biochemical parameter for evaluating lung damage during preservation. Transplantation. 1994; 57: 194–198
   PubMed Web of Science ®Google Scholar
• Morganroth M L, Till G O, Schoeneich S, Ward P A. Eicosanoids are involved in the permeability changes but not the pulmonary hypertension after systemic activation of complement. Lab Invest. 1988; 58: 316–323
   PubMed Web of Science ®Google Scholar
• Yoshimura K, Tod M L, Pier K G, Rubin L J. Effects of a thromboxane A2 analogue and prostacyclin on lung fluid balance in newborn lambs. Circ Res. 1989; 65: 1409–1416
   PubMed Web of Science ®Google Scholar
• Sundaresan S, Alevy Y G, Steward N, et al. Cytokine gene transcripts for tumor necrosis factor-alpha, interleukin-2, and interferon-gamma in human pulmonary allografts. J Heart Lung Transplant 1995; 14: 512–518
   PubMed Web of Science ®Google Scholar
• Naka Y, Roy D K, Smerling A J, et al. Inhaled nitric oxide fails to confer the pulmonary protection provided by distal stimulation of the nitric oxide pathway at the level of cyclic guanosine monophosphate. J Thorac Cardiovasc Surg. 1995; 110: 1434–1441
   PubMed Web of Science ®Google Scholar
• Chang S-W, Westcott J Y, Pickett W C, Murphy R C, Voelkel N F. Endotoxin-induced lung injury in rats: Role of eicosanoids. J Appl Physiol. 1989; 66: 2407–2418
   PubMed Web of Science ®Google Scholar
• Simon L S. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med. 1999; 106: 37S–42S
   PubMedGoogle Scholar
• Naraba H, Murakami M, Matsumoto H, et al. Segregated coupling of phospholipase A2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages. J Immunol. 1998; 160: 2974–2982
   PubMed Web of Science ®Google Scholar
• Zamora C A, Baron D A, Heffner J E. Thromboxane contributes to pulmonary hypertension in ischemia–reperfusion lung injury. J Appl Physiol. 1993; 74: 224–229
   PubMed Web of Science ®Google Scholar
• Vane J. Towards a better aspirin. Nature 1994; 367: 215–216
   PubMed Web of Science ®Google Scholar
• Nakamura K, Tsuji K, Konishi N, Matsuo M. Studies on anti-inflammatory agents.III. Synthesis and pharmacological properties of metabolites of 4′-acetyl-2′-(2,4-difluorophenoxy) methanesulfonanilide (FK3311). Chem Pharm Bull. 1993; 41: 2050–2052
   PubMed Web of Science ®Google Scholar
• Littner M R, Kazmi G M, Lott F D. Distribution of cyclooxygenase products with cyclooxygenase inhibition in isolated dog lung. J Appl Physiol. 1986; 61: 988–993
   PubMed Web of Science ®Google Scholar
• Post S, Goerig M, Otto G, et al. Prostanoid release in experimental liver transplantation. Transplantation. 1990; 49: 490–494
   PubMed Web of Science ®Google Scholar
• Turnage R H, Kadesky K M, Bartula L, Myers S I. Pulmonary thromboxane release following intestinal reperfusion. J Surg Res. 1995; 58: 552–557
   PubMed Web of Science ®Google Scholar
• Littner M R, Lott F D. Edema from cyclooxygenase products of endogenous arachidonic acid in isolated lung. J Appl Physiol. 1989; 67: 846–855
   PubMed Web of Science ®Google Scholar
• Takahashi T. The effects of thromboxane A2 synthetase inhibitor (OKY-046) on complete hepatic ischemia in rats with obstructive jaundice. Surg Today. 1996; 26: 15–20
   PubMed Web of Science ®Google Scholar
• Yoshimura K, Tod M L, Pier K G, Rubin L. Role of venoconstriction in thromboxane-induced pulmonary hypertension and edema in lambs. J Appl Physiol. 1989; 66: 929–935
   PubMed Web of Science ®Google Scholar
• Isozaki H, Okajima K, Hara H, Kobayashi M. The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury. Surg Today. 1994; 24: 435–440
   PubMed Web of Science ®Google Scholar
• Soejima Y, Yanaga K, Nasizaki T, Yoshizumi T, Uchiyama H, Sugimachi K. Effect of thromboxane synthetase inhibitor on non-heart-beating donors in rat orthotopic liver transplantation. Surgery. 1998; 123: 67–72
   PubMed Web of Science ®Google Scholar
• Jiang X-W, Kambara K, Gotoh N, Nishigaki K, Fujiwara H. Effects of low-dose beraprost sodium, a stable prostaglandin I2 analogue, on reperfusion injury to rabbit lungs. Am J Respir Crit Care Med. 1998; 158: 1669–1675
   PubMed Web of Science ®Google Scholar
• Yamashita C, Oobo H, Tsuji F, et al. Effect of prostaglandin I2 and superoxide dismutase on reperfusion injury of warm ischemic lung. Ann Thorac Surg. 1992; 54: 921–924
   PubMed Web of Science ®Google Scholar
• Hasturk S, Kemp B, Kalapurakal S K, Kurie J M, Hong W K, Lee J S. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma. Cancer. 2002; 94: 1023–1031
   PubMed Web of Science ®Google Scholar
• Ochi T, Senoh H. Anti-inflammatory and analgesic effects of FK3311, a selective inhibitor of cyclooxygenase in inflamed tissues. Jpn J Pharmacol. 1993; 61: 333
   PubMedGoogle Scholar